COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,436 Articles (22,835 medRxiv, 8,601 bioRxiv)

Most recent first Previous |  Page 1902: Articles 19011-19020  | Next

Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
Bhaskaran, K., Bacon, S. C., Evans, S. J., Bates, C. J., Rentsch, C. T., Brian, M., Tomlinson, L., Walker, A. J., Schultze, A., Morton, C. E., Grint, D., Mehrkar, A., Eggo, R. M., Inglesby, P., Douglas, I. J., McDonald, H. I., Cockburn, J., Williamson, E. J., Evans, D., Curtis, H. J., Hulme, W. J., Parry, J., Hester, F., Harper, S., Spiegelhalter, D., Smeeth, L., Goldacre, B.
10.1101/2021.01.15.21249756 — Posted: 2021-01-20
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV 2 infection
Gupta, R. K., Rosenheim, J., Bell, L. C. K., Chandran, A., Guerra-Assuncao, J. A., Pollara, G., Whelan, M., Artico, J., Joy, G., Kurdi, H., Altmann, D. M., Boyton, R., Maini, M., McKnight, A., Lambourne, J., Cutino-moguel, T., Manisty, C., Treibel, T. A., Moon, J., Chain, B., Noursadeghi, M., The COVIDsortium Investigators
10.1101/2021.01.18.21250044 — Posted: 2021-01-20
Endothelial cell-activating antibodies in COVID-19
Shi, H., Zuo, Y., Gandhi, A. A., Sule, G., Yalavarthi, S., Gockman, K., Madison, J. A., Zuo, M., Shi, Y., Knight, J. S., Kanthi, Y.
10.1101/2021.01.18.21250041 — Posted: 2021-01-20
NEWS2 and laboratory predictors correlated with clinical deterioration in hospitalised patients with COVID-19
Tuncer, G., Surme, S., Bayramlar, O. F., Karanalbant, H. K., Copur, B., Yazla, M., Zerdali, E., Yilmaz-Nakir, I., Kurt-Cinar, A. R., Buyukyazgan, A., Balli, H., Kurekci, Y., Simsek-Yavuz, S., Sonmez, M. M., Sengoz, G., Pehlivanoglu, F.
10.1101/2021.01.17.21249878 — Posted: 2021-01-20
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma
Ma, T., Wiggins, C. C., Kornatowski, B. M., Hailat, R. S., Clayburn, A. C., Guo, W., Johnson, P. W., Senefeld, J. W., Klassen, S. A., Baker, S. E., Bruno, K. A., Fairweather, D., Wright, R. S., Carter, R. E., Li, C., Joyner, M. J., Paneth, N.
10.1101/2021.01.19.21249678 — Posted: 2021-01-20
Clinical utility of Corona Virus Disease-19 serum IgG, IgM, and neutralizing antibodies and inflammatory markers
Schaefer, E. J., Comite, F., Dulipsingh, L., Lang, M., Jimison, J., Grajower, M. M., Lebowitz, N. E., Geller, A. S., Diffenderfer, M. R., He, L., Breton, G., Dansinger, M. L., Saida, B., Yuan, C.
10.1101/2021.01.19.21249604 — Posted: 2021-01-20
Emergence of a novel SARS-CoV-2 strain in Southern California, USA
Zhang, W., Davis, B., Chen, S. S., Sincuir Martinez, J., Plummer, J. T., Vail, E.
10.1101/2021.01.18.21249786 — Posted: 2021-01-20 Discussion: Offsite
City Reduced Probability of Infection (CityRPI) for Indoor Airborne Transmission of SARS-CoV-2 and Urban Building Energy Impacts
Katal, A., Albettar, M., Wang, L.
10.1101/2021.01.19.21250046 — Posted: 2021-01-20
Issues of Random Sampling with Rapid Antigen Tests for COVID-19 Diagnosis: A Special Reference to Kalmunai RDHS Division
Mohamed, R. A., Junaideen, S. M.
10.1101/2021.01.11.21249636 — Posted: 2021-01-20
Optimizing SARS-CoV-2 vaccination strategies in France: Results from a stochastic agent-based model
Hoertel, N., Blachier, M., Limosin, F., Sanchez-Rico, M., Blanco, C., Olfson, M., Luchini, S., Schwarzinger, M., Leleu, H.
10.1101/2021.01.17.21249970 — Posted: 2021-01-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).